Barclays PLC Lensar, Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Lensar, Inc. stock. As of the latest transaction made, Barclays PLC holds 13,468 shares of LNSR stock, worth $137,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,468
Previous 16,770
19.69%
Holding current value
$137,373
Previous $221,000
26.24%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LNSR
# of Institutions
90Shares Held
5.19MCall Options Held
68.4KPut Options Held
3.4K-
North Run Capital, LP Wellesley, MA1.1MShares$11.2 Million7.54% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA778KShares$7.93 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA508KShares$5.18 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX225KShares$2.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA218KShares$2.22 Million0.0% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $112M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...